Zurcher Kantonalbank (Zurich Cantonalbank) Bristol Myers Squibb CO Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,430,817 shares of BMY stock, worth $72.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,430,817

Previous 900,704 58.86%

Holding current value

$72.9 Million

Previous $48.8 Million 21.65%

% of portfolio

0.2%

Previous 0.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $21.3 Million - $28.1 Million	530,113 Added 58.86%	1,430,817 $59.4 Million
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $544,812 - $617,712	-11,355 Reduced 1.24%	900,704 $48.8 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $11 Million - $13.1 Million	-226,406 Reduced 19.89%	912,059 $46.8 Million
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $3.93 Million - $4.4 Million	-67,943 Reduced 5.63%	1,138,465 $66.1 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $777,962 - $863,806	12,211 Added 1.02%	1,206,408 $77.1 Million
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $8.23 Million - $9.33 Million	125,204 Added 11.71%	1,194,197 $82.8 Million
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $1.2 Million - $1.42 Million	17,557 Added 1.67%	1,068,993 $76.9 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $2,766 - $1.64 Million	21,281 Added 2.07%	1,051,436 $74.7 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $5.37 Million - $5.92 Million	-73,993 Reduced 6.7%	1,030,155 $79.3 Million
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $8.14 Million - $9.76 Million	132,341 Added 13.62%	1,104,148 $80.6 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $7.61 Million - $8.87 Million	-141,867 Reduced 12.74%	971,807 $60.6 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $2.18 Million - $2.55 Million	-36,796 Reduced 3.2%	1,113,674 $65.9 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $3.45 Million - $3.75 Million	55,675 Added 5.09%	1,150,470 $76.9 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $11.3 Million - $12.8 Million	191,148 Added 21.15%	1,094,795 $69.1 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $913,446 - $1.04 Million	-15,820 Reduced 1.72%	903,647 $56.1 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $7.05 Million - $7.82 Million	122,813 Added 15.42%	919,467 $55.4 Million
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $11.1 Million - $13 Million	-202,531 Reduced 20.27%	796,654 $46.8 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $11.7 Million - $17.1 Million	252,961 Added 33.9%	999,185 $55.7 Million
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $17.9 Million - $23.3 Million	363,278 Added 94.86%	746,224 $47.9 Million
Q3 2019 Oct 18, 2019	SELL	$42.77 - $50.71 $171,208 - $202,992	-4,003 Reduced 1.03%	382,946 $19.4 Million
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $6.6 Million - $7.3 Million	-147,852 Reduced 27.65%	386,949 $17.5 Million
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $7.53 Million - $8.98 Million	166,852 Added 45.35%	534,801 $25.5 Million
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $47,589 - $61,712	-976 Reduced 0.26%	367,949 $19.1 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $296,425 - $334,344	-5,371 Reduced 1.43%	368,925 $22.9 Million
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $643,651 - $802,239	-12,738 Reduced 3.29%	374,296 $20.7 Million
Q1 2018 May 03, 2018	BUY	$59.92 - $68.98 $1.41 Million - $1.62 Million	23,470 Added 6.46%	387,034 $24.5 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $157,582 - $171,805	-2,629 Reduced 0.72%	363,564 $22.3 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $20.2 Million - $23.3 Million	366,193	366,193 $23.3 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Bristol Myers Squibb CO Transaction History